These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 19139835)
1. Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer. Haley ES; Au GG; Carlton BR; Barry RD; Shafren DR J Mol Med (Berl); 2009 Apr; 87(4):385-99. PubMed ID: 19139835 [TBL] [Abstract][Full Text] [Related]
2. Potent oncolytic activity of human enteroviruses against human prostate cancer. Berry LJ; Au GG; Barry RD; Shafren DR Prostate; 2008 May; 68(6):577-87. PubMed ID: 18288643 [TBL] [Abstract][Full Text] [Related]
3. Oncolysis of human ovarian cancers by echovirus type 1. Shafren DR; Sylvester D; Johansson ES; Campbell IG; Barry RD Int J Cancer; 2005 Jun; 115(2):320-8. PubMed ID: 15688406 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of oncolytic reovirus against human gastric cancer with peritoneal metastasis in experimental animal model. Kawaguchi K; Etoh T; Suzuki K; Mitui MT; Nishizono A; Shiraishi N; Kitano S Int J Oncol; 2010 Dec; 37(6):1433-8. PubMed ID: 21042711 [TBL] [Abstract][Full Text] [Related]
5. Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer. Zhou W; Dai S; Zhu H; Song Z; Cai Y; Lee JB; Li Z; Hu X; Fang B; He C; Huang X Gene Ther; 2017 Apr; 24(4):199-207. PubMed ID: 28075429 [TBL] [Abstract][Full Text] [Related]
6. Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer. Song KY; Wong J; Gonzalez L; Sheng G; Zamarin D; Fong Y J Mol Med (Berl); 2010 Jun; 88(6):589-96. PubMed ID: 20393691 [TBL] [Abstract][Full Text] [Related]
7. Imaging and Antitumoral Effect of a Cyclo-oxygenase 2-specific Replicative Adenovirus for Small Metastatic Gastric Cancer Lesions. Kosaka T; Davydova J; Ono HA; Akiyama H; Hirai S; Ohno S; Takeshita F; Aoki K; Ochiya T; Yamamoto M; Kunisaki C; Endo I Anticancer Res; 2015 Oct; 35(10):5201-10. PubMed ID: 26408678 [TBL] [Abstract][Full Text] [Related]
8. Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases. Yang A; Zhang Z; Chaurasiya S; Park AK; Jung A; Lu J; Kim SI; Priceman S; Fong Y; Woo Y J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37019471 [TBL] [Abstract][Full Text] [Related]
9. Adenoviral oncolytic suicide gene therapy for a peritoneal dissemination model of gastric cancer in mice. Imamura Y; Ishikawa S; Sato N; Karashima R; Hirashima K; Hiyoshi Y; Nagai Y; Koga Y; Hayashi N; Watanabe M; Yamada G; Baba H Ann Surg Oncol; 2010 Feb; 17(2):643-52. PubMed ID: 20012217 [TBL] [Abstract][Full Text] [Related]
10. Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1. Lin MT; Chang CC; Lin BR; Yang HY; Chu CY; Wu MH; Kuo ML J Biol Chem; 2007 Nov; 282(47):34594-604. PubMed ID: 17905740 [TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination. Takakura M; Nakamura M; Kyo S; Hashimoto M; Mori N; Ikoma T; Mizumoto Y; Fujiwara T; Urata Y; Inoue M Cancer Gene Ther; 2010 Jan; 17(1):11-9. PubMed ID: 19662088 [TBL] [Abstract][Full Text] [Related]
12. Combination of the tumor angiogenesis inhibitor bevacizumab and intratumoral oncolytic herpes virus injections as a treatment strategy for human gastric cancers. Deguchi T; Shikano T; Kasuya H; Nawa A; Fujiwara S; Takeda S; Gewen T; Sahin TT; Yamada S; Kanzaki A; Yamamura K; Fujii T; Sugimoto H; Nomoto S; Fukuda S; Nishikawa Y; Kodera Y; Nakao A Hepatogastroenterology; 2012 Sep; 59(118):1844-50. PubMed ID: 22172413 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis. Eveno C; Mojica K; Ady JW; Thorek DL; Longo V; Belin LJ; Gholami S; Johnsen C; Zanzonico P; Chen N; Yu T; Szalay AA; Fong Y Surgery; 2015 Feb; 157(2):331-7. PubMed ID: 25616946 [TBL] [Abstract][Full Text] [Related]
14. Anti-Tumor Immunogenicity of the Oncolytic Virus CF33-hNIS-antiPDL1 against Ex Vivo Peritoneal Cells from Gastric Cancer Patients. Zhang Z; Yang A; Chaurasiya S; Park AK; Kim SI; Lu J; Valencia H; Fong Y; Woo Y Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762490 [TBL] [Abstract][Full Text] [Related]
15. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer. Tsuji T; Nakamori M; Iwahashi M; Nakamura M; Ojima T; Iida T; Katsuda M; Hayata K; Ino Y; Todo T; Yamaue H Int J Cancer; 2013 Jan; 132(2):485-94. PubMed ID: 22729516 [TBL] [Abstract][Full Text] [Related]
16. Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy. Wang W; Ji W; Hu H; Ma J; Li X; Mei W; Xu Y; Hu H; Yan Y; Song Q; Li Z; Su C Oncotarget; 2014 Jan; 5(1):150-60. PubMed ID: 24473833 [TBL] [Abstract][Full Text] [Related]
17. Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer. Sako A; Kitayama J; Koyama H; Ueno H; Uchida H; Hamada H; Nagawa H Cancer Res; 2004 May; 64(10):3624-8. PubMed ID: 15150121 [TBL] [Abstract][Full Text] [Related]
18. IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice. Thomas ED; Meza-Perez S; Bevis KS; Randall TD; Gillespie GY; Langford C; Alvarez RD J Ovarian Res; 2016 Oct; 9(1):70. PubMed ID: 27784340 [TBL] [Abstract][Full Text] [Related]
19. Gene expression changes induced by HIPEC in a murine model of gastric cancer. Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714 [TBL] [Abstract][Full Text] [Related]